Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

UCLA's Dr. Antoni Ribas Discusses PD1 and PD-L1 Targeted Cancer Drugs

POSTED: Mar. 22, 2013 Share

Antoni Ribas, M.D. of UCLA's Jonsson Comprehensive Cancer Center is involved in trials testing new cancer drugs targeting the cell surface molecule called PD-L1 and the immune cell receptors PD1. Early data from these trials involving non-small cell lung cancer, renal cancer and melanoma have demonstrated impressive results that can lead to new treatments for the disease. In the video interview, Dr. Ribas explains the trial test data published so far, and previews new data to come.


Last updated: 4/4/2013 2:48:08 PM